We are live on ! Find out more
DSC

Duncker Streett & Co Portfolio holdings

AUM $526M
1-Year Est. Return 22.2%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+22.2%
3 Year Est. Return
+74.69%
5 Year Est. Return
+94.09%
10 Year Est. Return
+300.66%
AUM
$247M
AUM Growth
-$14.1M
Cap. Flow
-$24.5M
Cap. Flow %
-9.92%
Top 10 Hldgs %
19.87%
Holding
570
New
14
Increased
107
Reduced
149
Closed
11

Top Buys

Rank Stock Value
1
HP icon
Helmerich & Payne
HP
+$211K
2
ROP icon
Roper Technologies
ROP
+$138K
3
MRK icon
Merck
MRK
+$135K
4
VV icon
Vanguard Large-Cap ETF
VV
+$116K
5
KMI icon
Kinder Morgan
KMI
+$88.2K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$1.77M
2
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$1.58M
3
KMP
KINDER MORGAN ENER PNTRS L.P.
KMP
+$808K
4
TPR icon
Tapestry
TPR
+$674K
5
EPD icon
Enterprise Products Partners
EPD
+$646K

Sector Composition

Rank Sector Weight
1 Healthcare 16.26%
2 Energy 13.41%
3 Industrials 11.67%
4 Financials 10.92%
5 Technology 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
1
ExxonMobil
XOM
$646B
$11.3M 4.56%
130,873
-1,178
-0.9% -$106K
DHR icon
2
Danaher
DHR
$140B
$5.01M 2.03%
107,500
-9,755
-8% -$442K
IBM icon
3
IBM
IBM
$208B
$4.98M 2.01%
28,108
-2,103
-7% -$382K
GE icon
4
GE Aerospace
GE
$377B
$4.82M 1.95%
42,084
-3,233
-7% -$371K
MA icon
5
Mastercard
MA
$494B
$4.41M 1.78%
65,470
-2,700
-4% -$170K
CVX icon
6
Chevron
CVX
$380B
$4.17M 1.69%
34,321
-2,642
-7% -$325K
PG icon
7
Procter & Gamble
PG
$355B
$3.98M 1.61%
52,619
-1,718
-3% -$137K
TMO icon
8
Thermo Fisher Scientific
TMO
$214B
$3.78M 1.53%
41,014
-3,066
-7% -$277K
ECL icon
9
Ecolab
ECL
$79.6B
$3.7M 1.5%
37,424
-3,336
-8% -$310K
HSIC icon
10
Henry Schein
HSIC
$9.69B
$2.98M 1.21%
73,126
+680
+0.9% +$27.5K
PFE icon
11
Pfizer
PFE
$144B
$2.81M 1.14%
103,183
+19
+0% +$517
EMR icon
12
Emerson Electric
EMR
$84.5B
$2.75M 1.11%
42,484
-800
-2% -$48.9K
BAC icon
13
Bank of America
BAC
$436B
$2.73M 1.11%
197,858
-375
-0.2% -$5.35K
ITW icon
14
Illinois Tool Works
ITW
$85.7B
$2.71M 1.1%
35,513
-3,664
-9% -$268K
MRK icon
15
Merck
MRK
$331B
$2.68M 1.09%
59,017
+2,953
+5% +$135K
QCOM icon
16
Qualcomm
QCOM
$176B
$2.61M 1.06%
38,797
-5,622
-13% -$369K
ABBV icon
17
AbbVie
ABBV
$467B
$2.54M 1.03%
56,718
-1,478
-3% -$65.5K
IGSB icon
18
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$2.48M 1.01%
47,210
+306
+0.7% +$16.1K
PFF icon
19
iShares Preferred and Income Securities ETF
PFF
$13.2B
$2.45M 0.99%
64,531
-825
-1% -$31.5K
JNJ icon
20
Johnson & Johnson
JNJ
$656B
$2.37M 0.96%
27,352
-2,171
-7% -$195K
JNK icon
21
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.05B
$2.31M 0.94%
19,354
-124
-0.6% -$14.8K
BMY icon
22
Bristol-Myers Squibb
BMY
$132B
$2.22M 0.9%
47,883
+11
+0% +$483
VFC icon
23
VF Corp
VFC
$6.93B
$2.2M 0.89%
47,025
-9,558
-17% -$441K
NKE icon
24
Nike
NKE
$63.9B
$2.17M 0.88%
59,814
-14,066
-19% -$459K
SYK icon
25
Stryker
SYK
$134B
$2.17M 0.88%
32,095
-1,400
-4% -$96.7K
1
2 3 4 5

Similar funds

OC
Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return
IA
Insight Advisors Newtown, Pennsylvania $525M AUM 15.94% 1-Year Est. Return
FWM
Fonville Wealth Management Richmond, Virginia $525M AUM 16.61% 1-Year Est. Return
DA
Drake & Associates Waukesha, Wisconsin $525M AUM 14.04% 1-Year Est. Return
SLC
Second Line Capital Metairie, Louisiana $528M AUM 16.68% 1-Year Est. Return
SRFM
Shannon River Fund Management New York $524M AUM 90.54% 1-Year Est. Return
CM
Conifer Management New York $524M AUM 14.11% 1-Year Est. Return
ETS
ESL Trust Services Rochester, New York $524M AUM 17.18% 1-Year Est. Return

Duncker Streett & Co's Q3 2013 Portfolio in Review

As of Q3 2013, Duncker Streett & Co held 570 positions worth $247M, down 5.4% from $261M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Duncker Streett & Co withdrew a net $24.5M in Q3 2013, closing 11 positions and reducing 149 holdings. Its most notable exit was Allergan plc, an estimated $1.77M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Energy and Industrials.

Against the trend, Duncker Streett & Co opened a new position in Helmerich & Payne worth $221K.

  • Duncker Streett & Co's largest Q3 2013 buy was Helmerich & Payne: 3,200 shares worth $221K.
  • Duncker Streett & Co added most to Merck in Q3 2013, an estimated $135K increase.
  • Duncker Streett & Co's biggest Q3 2013 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.58M.
  • Duncker Streett & Co fully exited Allergan plc in Q3 2013, selling an estimated $1.77M.
  • Duncker Streett & Co's ten largest holdings make up 20% of its $247M portfolio in Q3 2013.
  • Duncker Streett & Co opened 14 new positions and closed 11 in Q3 2013.
  • Duncker Streett & Co's portfolio value fell 5.4% quarter-over-quarter to $247M.

Based on Duncker Streett & Co's 13F filing for Q3 2013, filed 23 Oct 2013.